BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis 2019;68:S193-9. [PMID: 30957165 DOI: 10.1093/cid/ciz002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoffmann JP, Friedman JK, Wang Y, McLachlan JB, Sammarco MC, Morici LA, Roy CJ. In situ Treatment With Novel Microbiocide Inhibits Methicillin Resistant Staphylococcus aureus in a Murine Wound Infection Model. Front Microbiol 2019;10:3106. [PMID: 32038549 DOI: 10.3389/fmicb.2019.03106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
2 Ziesmer J, Tajpara P, Hempel NJ, Ehrström M, Melican K, Eidsmo L, Sotiriou GA. Vancomycin-Loaded Microneedle Arrays against Methicillin-Resistant Staphylococcus Aureus Skin Infections. Adv Mater Technol 2021;6:2001307. [PMID: 34307835 DOI: 10.1002/admt.202001307] [Reference Citation Analysis]
3 Oliva A, Stefani S, Venditti M, Di Domenico EG. Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin. Front Microbiol 2021;12:749685. [PMID: 34745053 DOI: 10.3389/fmicb.2021.749685] [Reference Citation Analysis]
4 Lee B, Olaniyi R, Kwiecinski JM, Wardenburg JB. Staphylococcus aureus toxin suppresses antigen-specific T cell responses. J Clin Invest 2020;130:1122-7. [PMID: 31873074 DOI: 10.1172/JCI130728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
5 Namukobe J, Sekandi P, Byamukama R, Murungi M, Nambooze J, Ekyibetenga Y, Nagawa CB, Asiimwe S. Antibacterial, antioxidant, and sun protection potential of selected ethno medicinal plants used for skin infections in Uganda. Trop Med Health 2021;49:49. [PMID: 34130746 DOI: 10.1186/s41182-021-00342-y] [Reference Citation Analysis]
6 Hoang TPN, Ghori MU, Conway BR. Topical Antiseptic Formulations for Skin and Soft Tissue Infections. Pharmaceutics 2021;13:558. [PMID: 33921124 DOI: 10.3390/pharmaceutics13040558] [Reference Citation Analysis]
7 Gao Y, Zhang W, Cheng YF, Cao Y, Xu Z, Xu LQ, Kang Y, Xue P. Intradermal administration of green synthesized nanosilver (NS) through film-coated PEGDA microneedles for potential antibacterial applications. Biomater Sci 2021;9:2244-54. [PMID: 33514957 DOI: 10.1039/d0bm02136a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang B, Yao Y, Wei P, Song C, Wan S, Yang S, Zhu GM, Liu HM. Housefly Phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo. Int J Biol Macromol 2021;167:1424-34. [PMID: 33202277 DOI: 10.1016/j.ijbiomac.2020.11.096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kranjec C, Morales Angeles D, Torrissen Mårli M, Fernández L, García P, Kjos M, Diep DB. Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives. Antibiotics (Basel) 2021;10:131. [PMID: 33573022 DOI: 10.3390/antibiotics10020131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Al Kindi A, Alkahtani AM, Nalubega M, El-Chami C, O'Neill C, Arkwright PD, Pennock JL. Staphylococcus aureus Internalized by Skin Keratinocytes Evade Antibiotic Killing. Front Microbiol 2019;10:2242. [PMID: 31608046 DOI: 10.3389/fmicb.2019.02242] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
11 Felgueiras HP. An Insight into Biomolecules for the Treatment of Skin Infectious Diseases. Pharmaceutics 2021;13:1012. [PMID: 34371704 DOI: 10.3390/pharmaceutics13071012] [Reference Citation Analysis]
12 Wilcox MH, Dryden M. Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections. J Antimicrob Chemother 2021;76:iv2-8. [PMID: 34849996 DOI: 10.1093/jac/dkab350] [Reference Citation Analysis]
13 Welte T, Scheeren TW, Overcash JS, Saulay M, Engelhardt M, Hamed K. Efficacy and safety of ceftobiprole in patients aged 65 years or older: a post hoc analysis of three Phase III studies. Future Microbiol 2021;16:543-55. [PMID: 33960817 DOI: 10.2217/fmb-2021-0042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bassetti M, Del Puente F, Magnasco L, Giacobbe DR. Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials. Expert Opin Investig Drugs 2020;29:495-506. [PMID: 32242469 DOI: 10.1080/13543784.2020.1750595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Kulshreshtha G, Ahmed TAE, Wu L, Diep T, Hincke MT. A novel eco-friendly green approach to produce particalized eggshell membrane (PEM) for skin health applications. Biomater Sci 2020;8:5346-61. [PMID: 32857070 DOI: 10.1039/d0bm01110j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Doostan M, Maleki H, Doostan M, Khoshnevisan K, Faridi-Majidi R, Arkan E. Effective antibacterial electrospun cellulose acetate nanofibrous patches containing chitosan/erythromycin nanoparticles. Int J Biol Macromol 2021;168:464-73. [PMID: 33316335 DOI: 10.1016/j.ijbiomac.2020.11.174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Eckmann C, Tulkens PM. Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics. J Antimicrob Chemother 2021;76:iv9-iv22. [PMID: 34849999 DOI: 10.1093/jac/dkab351] [Reference Citation Analysis]
18 Feng P, Qiu H, Luo Y, Hu J, Cao Y, Pang Q, Mou X, Hou R, Hou W, Zhu Y. Development of Poloxamer Hydrogels Containing Antibacterial Guanidine-Based Polymers for Healing of Full-Thickness Skin Wound. ACS Biomater Sci Eng 2021;7:4557-68. [PMID: 34423628 DOI: 10.1021/acsbiomaterials.1c00600] [Reference Citation Analysis]
19 Rogne T, Liyanarachi KV, Rasheed H, Thomas LF, Flatby HM, Stenvik J, Løset M, Gill D, Burgess S, Willer CJ, Hveem K, Åsvold BO, Brumpton BM, DeWan AT, Solligård E, Damås JK. GWAS Identifies LINC01184/SLC12A2 as a Risk Locus for Skin and Soft Tissue Infections. J Invest Dermatol 2021;141:2083-2086.e8. [PMID: 33662382 DOI: 10.1016/j.jid.2021.01.020] [Reference Citation Analysis]
20 Pai MP, Wilcox MH, Chitra S, McGovern PC. Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections. J Antimicrob Chemother 2021;76:1315-22. [PMID: 33458763 DOI: 10.1093/jac/dkaa558] [Reference Citation Analysis]
21 Burillo A, Bouza E. The eternal dilemma of antitoxin antibiotics for skin and soft tissue infection. Curr Opin Infect Dis 2021;34:80-8. [PMID: 33560018 DOI: 10.1097/QCO.0000000000000711] [Reference Citation Analysis]
22 Karpuz M, Atlihan-Gundogdu E, Demir ES, Senyigit Z. Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity. AAPS PharmSciTech 2021;22:62. [PMID: 33528714 DOI: 10.1208/s12249-020-01917-4] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Overcash JS, Kim C, Keech R, Gumenchuk I, Ninov B, Gonzalez-Rojas Y, Waters M, Simeonov S, Engelhardt M, Saulay M, Ionescu D, Smart JI, Jones ME, Hamed KA. Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET). Clin Infect Dis 2021;73:e1507-17. [PMID: 32897367 DOI: 10.1093/cid/ciaa974] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Poliseno M, Bavaro DF, Brindicci G, Luzzi G, Carretta DM, Spinarelli A, Messina R, Miolla MP, Achille TI, Dibartolomeo MR, Dell'Aera M, Saracino A, Angarano G, Favale S, D'Agostino C, Moretti B, Signorelli F, Taglietti C, Carbonara S. Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections. Clin Drug Investig 2021;41:437-48. [PMID: 33884583 DOI: 10.1007/s40261-021-01028-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yeroushalmi S, Shirazi JY, Friedman A. New Developments in Bacterial, Viral, and Fungal Cutaneous Infections. Curr Dermatol Rep 2020;9:152-65. [PMID: 32435525 DOI: 10.1007/s13671-020-00295-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sokolowski K, Pham HM, Wenzler E, Gemeinhart RA. Glutathione-Conjugated Hydrogels: Flexible Vehicles for Personalized Treatment of Bacterial Infections. Pharm Res 2021;38:1247-61. [PMID: 34117588 DOI: 10.1007/s11095-021-03057-1] [Reference Citation Analysis]
27 Saddler K, Zhang J, Sul J, Patel P, Castro-Lainez M, Stevens ML, Kosler S, Lowery E, Sierra-Hoffman M. Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital. PLoS One 2021;16:e0248129. [PMID: 33735185 DOI: 10.1371/journal.pone.0248129] [Reference Citation Analysis]
28 Karauzum H, Venkatasubramaniam A, Adhikari RP, Kort T, Holtsberg FW, Mukherjee I, Mednikov M, Ortines R, Nguyen NTQ, Doan TMN, Diep BA, Lee JC, Aman MJ. IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus. Front Immunol 2021;12:624310. [PMID: 33777005 DOI: 10.3389/fimmu.2021.624310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Perni S, Preedy EC, Prokopovich P. Amplify antimicrobial photo dynamic therapy efficacy with poly-beta-amino esters (PBAEs). Sci Rep 2021;11:7275. [PMID: 33790379 DOI: 10.1038/s41598-021-86773-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Jabbour JF, Kanj SS. Gram-Negative Skin and Soft Tissue Infections. Infect Dis Clin North Am 2021;35:157-67. [PMID: 33303333 DOI: 10.1016/j.idc.2020.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Thean LJ, Romani L, Engelman D, Jenney A, Wand H, Mani J, Paka J, Devi R, Sahukhan A, Kama M, Tuicakau M, Kado J, Carvalho N, Whitfeld M, Kaldor J, Steer AC. Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019. Am J Trop Med Hyg 2021:tpmd201459. [PMID: 34029210 DOI: 10.4269/ajtmh.20-1459] [Reference Citation Analysis]